{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:51:53Z","timestamp":1761486713617},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1053\/ejso.2000.1040","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:56:27Z","timestamp":1032443787000},"page":"340-342","source":"Crossref","is-referenced-by-count":32,"title":["Hyperthermia and hypoxia: new developments in anticancer chemotherapy"],"prefix":"10.1053","volume":"27","author":[{"given":"N","family":"Zaffaroni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Fiorentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"De Giorgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/ejso.2000.1040_RF1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/026567399285765","article-title":"For the clinical application of thermochemotherapy given at mild temperatures","volume":"2","author":"Urano","year":"1999","journal-title":"Int J Hyperther"},{"key":"10.1053\/ejso.2000.1040_RF2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/stem.5530070606","article-title":"Antitumor activity of hyperthermia alone or in combination with cisplatin and melphalan in primary cultures of human malignant melanoma","volume":"7","author":"Zaffaroni","year":"1989","journal-title":"Int J Cell Cloning"},{"key":"10.1053\/ejso.2000.1040_RF3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/02656739509022491","article-title":"Hyperthermia and platinum complexes: time between treatments and synergy in vitro and in vivo","volume":"11","author":"Kusumoto","year":"1995","journal-title":"Int J Hyperther"},{"key":"10.1053\/ejso.2000.1040_RF4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0360-3016(89)90028-X","article-title":"Effect of hyperthermia on the uptake and cytotoxicity of melphalan in Chinese hamster ovary cells","volume":"16","author":"Bates","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/ejso.2000.1040_RF5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/02656739209021789","article-title":"Effect of hyperthrmia on the formation and removal of DNA interstrand cross-links induced by melphalan in primary cultures of human malignant melanoma","volume":"8","author":"Zaffaroni","year":"1992","journal-title":"Int J Hyperther"},{"key":"10.1053\/ejso.2000.1040_RF6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2184.1995.tb00049.x","article-title":"Effect of melphalan and hyperthermia on cell cycle progression and cyclin B1 expression in human melanoma cells","volume":"28","author":"Orlandi","year":"1995","journal-title":"Cell Prolif"},{"key":"10.1053\/ejso.2000.1040_RF7","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1038\/bjc.1996.654","article-title":"Effect of melphalan and hyperthermia on p34cdc2 kinase activity in human melanoma cells","volume":"74","author":"Orlandi","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1053\/ejso.2000.1040_RF8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01212608","article-title":"Hyperthermia enhances the cytotoxic activity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells","volume":"123","author":"Rietbroek","year":"1997","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1053\/ejso.2000.1040_RF9","first-page":"523","article-title":"Relevance of cell kinetic and ploidy characteristics for the thermal response of malignant melanoma primary cultures","volume":"2","author":"Orlandi","year":"1993","journal-title":"Int J Oncol"},{"key":"10.1053\/ejso.2000.1040_RF10","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/bjc.1995.383","article-title":"Heat shock protein expression in testis and bladder cancer cell lines exhibiting differential sensitivity to heat","volume":"72","author":"Richards","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1053\/ejso.2000.1040_RF11","first-page":"1408","article-title":"The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy","volume":"58","author":"Brown","year":"1998","journal-title":"Cancer Res"},{"key":"10.1053\/ejso.2000.1040_RF12","first-page":"169","article-title":"Drug resistance mediated by cellular stress response to the microenvironment","volume":"14","author":"Tomida","year":"1999","journal-title":"Anti-Cancer Drug Design"},{"key":"10.1053\/ejso.2000.1040_RF13","first-page":"5863","article-title":"The hypoxic cell: A target for selective cancer therapy","volume":"59","author":"Brown","year":"1999","journal-title":"Cancer Res"},{"key":"10.1053\/ejso.2000.1040_RF14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0360-3016(98)00302-2","article-title":"Bioreductive therapies: An overview of drugs and their mechanisms of action","volume":"42","author":"Rauth","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/ejso.2000.1040_RF15","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1093\/annonc\/10.suppl_5.S29","article-title":"Tirapazamine: A new drug producing tumor specific enhancement of platinum-based chemotherapy in non-small-cell lung cancer","volume":"10 (Suppl. 5)","author":"Wouters","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1053\/ejso.2000.1040_RF16","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/sj.gt.3301001","article-title":"An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer","volume":"6","author":"Binley","year":"1999","journal-title":"Gene Ther"},{"key":"10.1053\/ejso.2000.1040_RF17","first-page":"2285","article-title":"Possible benefits of hyperthermia to chemotherapy","volume":"39","author":"Kowal","year":"1979","journal-title":"Cancer Res"},{"key":"10.1053\/ejso.2000.1040_RF18","first-page":"4721s","article-title":"Effect of local hyperthermia on blood flow and microenvironment: a review","volume":"44 (Suppl. 10)","author":"Song","year":"1984","journal-title":"Cancer Res"},{"key":"10.1053\/ejso.2000.1040_RF19","first-page":"3339","article-title":"Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma","volume":"50","author":"Teicher","year":"1990","journal-title":"Cancer Res"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798300910400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798300910400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T22:55:17Z","timestamp":1555023317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798300910400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S0748798300910400"],"URL":"https:\/\/doi.org\/10.1053\/ejso.2000.1040","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}